SEC 13F Intelligence

Norwest Venture Partners Xii, LP / HCAT

Norwest Venture Partners Xii, LP’s Health Catalyst Inc Position

Does Norwest Venture Partners Xii, LP own Health Catalyst Inc (HCAT)? Not currently — the last reported position was 876.0K shares worth $32M in Q3 2020; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$32M
Q3 2020
Shares
876.0K
% of Portfolio
+69.68%
Quarters Held
4
position exited

Position History HCAT

Reported value by quarter
Q4 ’19: $102MQ4 ’19Q1 ’20: $62MQ1 ’20Q2 ’20: $69MQ2 ’20Q3 ’20: $32MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2020876.0K$32M+69.68%
Q2 20202.35M$69M+79.76%
Q1 20202.35M$62M+100.00%
Q4 20192.95M$102M+100.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norwest Venture Partners Xii, LP’s full portfolio or all institutional holders of HCAT.